JP2025513384A5 - - Google Patents

Info

Publication number
JP2025513384A5
JP2025513384A5 JP2024561909A JP2024561909A JP2025513384A5 JP 2025513384 A5 JP2025513384 A5 JP 2025513384A5 JP 2024561909 A JP2024561909 A JP 2024561909A JP 2024561909 A JP2024561909 A JP 2024561909A JP 2025513384 A5 JP2025513384 A5 JP 2025513384A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
accumulation
disease
heparan sulfate
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024561909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513384A (ja
Filing date
Publication date
Priority claimed from IT102022000007808A external-priority patent/IT202200007808A1/it
Application filed filed Critical
Publication of JP2025513384A publication Critical patent/JP2025513384A/ja
Publication of JP2025513384A5 publication Critical patent/JP2025513384A5/ja
Pending legal-status Critical Current

Links

JP2024561909A 2022-04-20 2023-04-18 ヘパラン硫酸の蓄積を伴う疾患の処置のためのイミノ糖を含む治療用組成物 Pending JP2025513384A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT102022000007808A IT202200007808A1 (it) 2022-04-20 2022-04-20 Composizioni terapeutiche per malattie causate da accumulo di eparan solfato
IT102022000007808 2022-04-20
PCT/EP2023/059966 WO2023203004A1 (en) 2022-04-20 2023-04-18 Therapeutic compositions with imino sugars for the treatment of diseases with accumulation of heparan sulfate

Publications (2)

Publication Number Publication Date
JP2025513384A JP2025513384A (ja) 2025-04-24
JP2025513384A5 true JP2025513384A5 (enExample) 2026-04-20

Family

ID=82483266

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024561909A Pending JP2025513384A (ja) 2022-04-20 2023-04-18 ヘパラン硫酸の蓄積を伴う疾患の処置のためのイミノ糖を含む治療用組成物

Country Status (9)

Country Link
US (1) US20250255856A1 (enExample)
EP (1) EP4511032A1 (enExample)
JP (1) JP2025513384A (enExample)
CN (1) CN119136803A (enExample)
AU (1) AU2023257557A1 (enExample)
CA (1) CA3249619A1 (enExample)
IT (1) IT202200007808A1 (enExample)
MX (1) MX2024012934A (enExample)
WO (1) WO2023203004A1 (enExample)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2083205C1 (ru) 1994-01-19 1997-07-10 Товарищество с ограниченной ответственностью предприятие "БИОМ" Способ лечения мукополисахаридоза
RU2196988C2 (ru) 2000-04-19 2003-01-20 Государственный новосибирский областной клинический диагностический центр Способ диагностики мукополисахаридозов
US20040204379A1 (en) * 2000-06-19 2004-10-14 Cheng Seng H. Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
AU2002241853A1 (en) 2001-01-12 2002-07-24 Oxford Glycosciences (Uk) Ltd. Mucopolysaccharidosis therapies
JP2003265196A (ja) 2002-03-15 2003-09-24 Seikagaku Kogyo Co Ltd ムコ多糖症のスクリーニング方法
AUPS293002A0 (en) 2002-06-14 2002-07-04 Women's And Children's Hospital Identification of oligosaccharides and their use in the diagnosis and evaluation of mucopolysaccharidoses and other related disorders
KR100762945B1 (ko) 2004-09-08 2007-10-04 진동규 동물 세포주를 이용한 이듀로네이트-설파타제의 발현 방법및 그 발현을 위한 세포주
PL377180A1 (pl) 2005-09-21 2007-04-02 Instytut Farmaceutyczny Zastosowanie izoflawonów i ich pochodnych w leczeniu mukopolisacharydoz
US8105788B2 (en) 2005-12-08 2012-01-31 The University Of British Columbia Mucopolysaccharidosis (MPS) diagnostic methods, systems, kits and assays associated therewith
US20070161074A1 (en) 2005-12-27 2007-07-12 Daiichi Pharmaceutical Co., Ltd. Diagnostic method of mucopolysaccharidoses
KR101497194B1 (ko) * 2009-09-04 2015-02-27 유나이티드 세러퓨틱스 코오포레이션 오르토믹소바이러스 감염의 치료 방법
AU2010366066B2 (en) 2010-12-22 2016-01-14 Fondazione Telethon Therapeutic strategies to treat CNS pathology in mucopolysaccharidoses
WO2012177778A1 (en) 2011-06-20 2012-12-27 Mount Sinai School Of Medicine Anti-tnf- therapy for the mucopolysaccharidoses and other lysosomal disorders
HK1221871A1 (zh) * 2013-05-02 2017-06-16 The Chancellor, Masters And Scholars Of The University Of Oxford 使用亚氨基糖进行的糖脂抑制
WO2017201030A1 (en) * 2016-05-16 2017-11-23 Emergent Virology Llc Methods of treating viral infection

Similar Documents

Publication Publication Date Title
JP2024071370A5 (enExample)
JP2024516371A5 (enExample)
JP2020500862A5 (enExample)
JP2021063088A5 (enExample)
CN114072396A (zh) 作为dna-pk抑制剂的喹啉和噌啉衍生物
JP2021191784A5 (enExample)
JP2022068329A5 (enExample)
JP2025013344A5 (enExample)
JP2006523216A5 (enExample)
JP2021530451A5 (enExample)
JP2009502743A5 (enExample)
JP2022545835A5 (enExample)
JPWO2023027198A5 (enExample)
JP2008518890A5 (enExample)
JP2005521713A5 (enExample)
JP2020507589A5 (enExample)
JP2006509749A5 (enExample)
JP2020097577A5 (enExample)
JP2022533958A5 (enExample)
JP2024541569A5 (enExample)
JP2004528385A5 (enExample)
JP2023109937A5 (enExample)
JP2022552881A5 (enExample)
JPWO2023054732A5 (enExample)
JP2022541938A5 (enExample)